We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$16.8B
AUM Growth
+$245M
(+1.5%)
Cap. Flow
-$838M
Cap. Flow
% of AUM
-4.98%
Top 10 Holdings %
Top 10 Hldgs %
24.01%
Holding
277
New
42
Increased
50
Reduced
131
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$87.8M |
| 2 |
Ascendis Pharma A/S
ASND
|
+$78.8M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$77.7M |
| 4 |
WillScot Mobile Mini Holdings
WSC
|
+$74.7M |
| 5 |
S&P Global
SPGI
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLRN
Acceleron Pharma
XLRN
|
+$154M |
| 2 |
PayPal
PYPL
|
+$120M |
| 3 |
Synchrony
SYF
|
+$101M |
| 4 |
Mercado Libre
MELI
|
+$94.1M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$91.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.86% |
| 2 | Healthcare | 17.79% |
| 3 | Industrials | 14.72% |
| 4 | Consumer Discretionary | 11.56% |
| 5 | Financials | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tapestry
TPR
$32.8B
| $148M | 0.88% |
3,656,629
-99,903
| -3% | -$4.11M |
|
27
Arthur J. Gallagher & Co
AJG
$63.6B
| $147M | 0.87% |
866,449
+82,865
| +11% | +$13.5M |
|
28
Trex
TREX
$5.01B
| $146M | 0.86% |
1,077,588
-74,929
| -7% | -$8.99M |
|
29
Trane Technologies
TT
$106B
| $144M | 0.86% |
713,970
-35,715
| -5% | -$6.72M |
|
30
Qualcomm
QCOM
$176B
| $144M | 0.86% |
788,404
+6,252
| +0.8% | +$1M |
|
31
TransUnion
TRU
$15.3B
| $143M | 0.85% |
1,203,807
+17,292
| +1% | +$1.98M |
|
32
Nice
NICE
$5.97B
| $140M | 0.83% |
459,992
-15,341
| -3% | -$4.43M |
|
33
Global Payments
GPN
$22.8B
| $137M | 0.81% |
1,009,817
+397,714
| +65% | +$54.8M |
|
34
Morgan Stanley
MS
$340B
| $135M | 0.81% |
1,379,952
-53,494
| -4% | -$5.33M |
|
35
Applied Materials
AMAT
$428B
| $135M | 0.8% |
858,799
+242,893
| +39% | +$35.2M |
|
36
Costco
COST
$420B
| $133M | 0.79% |
233,408
-82,382
| -26% | -$42.2M |
|
37
National Vision
EYE
$1.81B
| $132M | 0.79% |
2,759,033
-205,896
| -7% | -$11M |
|
38
Thermo Fisher Scientific
TMO
$220B
| $126M | 0.75% |
188,828
-43,966
| -19% | -$27.5M |
|
39
Saia
SAIA
$9.72B
| $124M | 0.74% |
367,792
-68,346
| -16% | -$21.2M |
|
40
Intuit
INTU
$89B
| $121M | 0.72% |
188,030
-9,743
| -5% | -$6.01M |
|
41
DexCom
DXCM
$32B
| $118M | 0.7% |
881,696
+407,080
| +86% | +$58.5M |
|
|
BPMC
42
DELISTED
Blueprint Medicines
BPMC
| $118M | 0.7% |
1,098,691
-116,662
| -10% | -$12.2M |
|
43
Target
TGT
$68B
| $118M | 0.7% |
508,220
+78,858
| +18% | +$19.2M |
|
44
Avantor
AVTR
$9.19B
| $117M | 0.7% |
2,787,784
+713,043
| +34% | +$28.1M |
|
45
Douglas Emmett
DEI
$1.96B
| $117M | 0.69% |
3,488,589
+575,344
| +20% | +$19.5M |
|
46
IDEX
IEX
$17.3B
| $114M | 0.68% |
483,531
-35,396
| -7% | -$8.04M |
|
|
BLD
47
DELISTED
TopBuild
BLD
| $113M | 0.67% |
411,099
-33,540
| -8% | -$8.58M |
|
48
Live Nation Entertainment
LYV
$42.1B
| $112M | 0.67% |
936,047
-131,151
| -12% | -$14.1M |
|
49
Five Below
FIVE
$13.5B
| $111M | 0.66% |
536,644
-49,286
| -8% | -$9.69M |
|
50
Vail Resorts
MTN
$5.3B
| $109M | 0.65% |
333,500
+8,378
| +3% | +$2.86M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Westfield Capital Management held 277 positions worth $16.8B, up 1.5% from $16.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Westfield Capital Management withdrew a net $838M in Q4 2021, closing 33 positions and reducing 131 holdings. Its most notable exit was Acceleron Pharma, an estimated $154M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Westfield Capital Management opened a new position in Tesla worth $92.2M.
- Westfield Capital Management's largest Q4 2021 buy was Tesla: 261,813 shares worth $92.2M.
- Westfield Capital Management added most to Ascendis Pharma A/S in Q4 2021, an estimated $78.8M increase.
- Westfield Capital Management's biggest Q4 2021 reduction was PayPal, cutting an estimated $120M.
- Westfield Capital Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $154M.
- Westfield Capital Management's ten largest holdings make up 24% of its $16.8B portfolio in Q4 2021.
- Westfield Capital Management opened 42 new positions and closed 33 in Q4 2021.
- Westfield Capital Management's portfolio value rose 1.5% quarter-over-quarter to $16.8B.
Based on Westfield Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.